KEYBANK NATIONAL ASSOCIATION/OH historic quarter change: USA Bonds: Zero-Coupon Convertibles, Reduced
In zero-coupon convertible notes (no coupon in the filed class) (listed in the US), over 25 quarters from 2012-12-31 to 2026-06-30, KEYBANK NATIONAL ASSOCIATION/OH opened 9 positions, added to 19, reduced 62 and sold out of 42.
- Q4 2013: Stock INTERNATIONAL GAME TECHNOLOG; Country of operation —; Class NOTE 3.2; Principal before $1,655,000.
- Q4 2013: Stock TEVA PHARMACEUTICAL FIN LLC; Country of operation —; Class DBCV 0.2; Principal before $2,028,000.
- Q4 2013: Stock GILEAD SCIENCES INC; Country of operation —; Class NOTE 1.6; Principal before $2,500,000.
- Q4 2013: Stock ARCHER DANIELS MIDLAND CO; Country of operation —; Class NOTE 0.8; Principal before $1,570,000.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1089877), 25 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-07-28); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-04-24); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-01-30); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-04); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-04); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-04-28); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-06); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-10-31); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-07-31); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-14); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-09); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-10); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-11); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-13); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-10); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-07); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-12); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-07); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-13); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-14); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-13); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-13); Q2 2013 (2013-03-31 to 2013-06-30, filed 2013-12-23); Q1 2013 (2012-12-31 to 2013-03-31, filed 2013-12-23). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2000-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).
| Quarter | Stock | Country of operation | Class | Principal before | Principal after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q4 2013 | INTERNATIONAL GAME TECHNOLOG
CUSIP 459902AQ5 | | NOTE 3.2 | $1,655,000 | $1,112,000 | -543,000 | $1,831,000 | $1,179,000 | -$652,000 | 2014-02-13 |
|---|
| Q4 2013 | TEVA PHARMACEUTICAL FIN LLC
CUSIP 88163VAE9 | | DBCV 0.2 | $2,028,000 | $1,400,000 | -628,000 | $2,103,000 | $1,487,000 | -$616,000 | 2014-02-13 |
|---|
| Q4 2013 | GILEAD SCIENCES INC
CUSIP 375558AP8 | | NOTE 1.6 | $2,500,000 | $2,223,000 | -277,000 | $6,922,000 | $7,332,000 | +$410,000 | 2014-02-13 |
|---|
| Q4 2013 | ARCHER DANIELS MIDLAND CO
CUSIP 039483AW2 | | NOTE 0.8 | $1,570,000 | $1,140,000 | -430,000 | $1,597,000 | $1,206,000 | -$391,000 | 2014-02-13 |
|---|
| Q4 2013 | JEFFERIES GROUP INC NEW
CUSIP 472319AG7 | | DBCV 3.8 | $1,509,000 | $1,130,000 | -379,000 | $1,582,000 | $1,196,000 | -$386,000 | 2014-02-13 |
|---|
| Q4 2013 | PRICELINE COM INC
CUSIP 741503AN6 | | NOTE 1.2 | $982,000 | $932,000 | -50,000 | $3,258,000 | $3,556,000 | +$298,000 | 2014-02-13 |
|---|
| Q4 2013 | NEWMONT MINING CORP
CUSIP 651639AJ5 | | NOTE 1.6 | $1,942,000 | $1,842,000 | -100,000 | $2,141,000 | $1,879,000 | -$262,000 | 2014-02-13 |
|---|
| Q4 2013 | ALCOA INC
CUSIP 013817AT8 | | NOTE 5.2 | $1,209,000 | $1,089,000 | -120,000 | $1,557,000 | $1,804,000 | +$247,000 | 2014-02-13 |
|---|
| Q4 2013 | LAM RESEARCH CORP
CUSIP 512807AL2 | | NOTE 1.2 | $1,799,000 | $1,624,000 | -175,000 | $2,164,000 | $1,975,000 | -$189,000 | 2014-02-13 |
|---|
| Q4 2013 | PROLOGIS
CUSIP 74340XAT8 | | NOTE 3.2 | $1,553,000 | $1,423,000 | -130,000 | $1,758,000 | $1,588,000 | -$170,000 | 2014-02-13 |
|---|
| Q4 2013 | DOMINION RES INC VA NEW
CUSIP 25746UAT6 | | NOTE 2.1 | $695,000 | $600,000 | -95,000 | $1,287,000 | $1,151,000 | -$136,000 | 2014-02-13 |
|---|
| Q4 2013 | ALLEGHENY TECHNOLOGIES INC
CUSIP 01741RAD4 | | NOTE 4.2 | $977,000 | $863,000 | -114,000 | $1,014,000 | $892,000 | -$122,000 | 2014-02-13 |
|---|
| Q4 2013 | MICRON TECHNOLOGY INC
CUSIP 595112AX1 | | NOTE 3.1 | $554,000 | $495,000 | -59,000 | $1,051,000 | $1,127,000 | +$76,000 | 2014-02-13 |
|---|
| Q4 2013 | OMNICOM GROUP INC
CUSIP 681919AV8 | | NOTE | $423,000 | $333,000 | -90,000 | $510,000 | $438,000 | -$72,000 | 2014-02-13 |
|---|
| Q4 2013 | DANAHER CORP DEL
CUSIP 235851AF9 | | NOTE | $1,154,000 | $1,029,000 | -125,000 | $2,325,000 | $2,309,000 | -$16,000 | 2014-02-13 |
|---|
| Q3 2013 | ARES CAP CORP
CUSIP 04010LAD5 | | NOTE 5.1 | $2,042,000 | $1,419,000 | -623,000 | $2,172,000 | $1,495,000 | -$677,000 | 2013-11-13 |
|---|
| Q3 2013 | NUANCE COMMUNICATIONS INC
CUSIP 67020YAF7 | | NOTE 2.7 | $957,000 | $423,000 | -534,000 | $986,000 | $427,000 | -$559,000 | 2013-11-13 |
|---|
| Q3 2013 | TEVA PHARMACEUTICAL FIN LLC
CUSIP 88163VAE9 | | DBCV 0.2 | $2,333,000 | $2,028,000 | -305,000 | $2,444,000 | $2,103,000 | -$341,000 | 2013-11-13 |
|---|
| Q3 2013 | ARCHER DANIELS MIDLAND CO
CUSIP 039483AW2 | | NOTE 0.8 | $1,919,000 | $1,570,000 | -349,000 | $1,935,000 | $1,597,000 | -$338,000 | 2013-11-13 |
|---|
| Q3 2013 | LAM RESEARCH CORP
CUSIP 512807AL2 | | NOTE 1.2 | $2,249,000 | $1,799,000 | -450,000 | $2,495,000 | $2,164,000 | -$331,000 | 2013-11-13 |
|---|
| Q3 2013 | GILEAD SCIENCES INC
CUSIP 375558AP8 | | NOTE 1.6 | $2,916,000 | $2,500,000 | -416,000 | $6,599,000 | $6,922,000 | +$323,000 | 2013-11-13 |
|---|
| Q3 2013 | AIRTRAN HLDGS INC
CUSIP 00949PAD0 | | NOTE 5.2 | $1,622,000 | $1,337,000 | -285,000 | $2,309,000 | $1,986,000 | -$323,000 | 2013-11-13 |
|---|
| Q3 2013 | DANAHER CORP DEL
CUSIP 235851AF9 | | NOTE | $1,437,000 | $1,154,000 | -283,000 | $2,644,000 | $2,325,000 | -$319,000 | 2013-11-13 |
|---|
| Q3 2013 | PROLOGIS
CUSIP 74340XAT8 | | NOTE 3.2 | $1,789,000 | $1,553,000 | -236,000 | $2,065,000 | $1,758,000 | -$307,000 | 2013-11-13 |
|---|
| Q3 2013 | E M C CORP MASS
CUSIP 268648AM4 | | NOTE 1.7 | $3,325,000 | $2,890,000 | -435,000 | $4,913,000 | $4,619,000 | -$294,000 | 2013-11-13 |
|---|
| Q3 2013 | ALCOA INC
CUSIP 013817AT8 | | NOTE 5.2 | $1,457,000 | $1,209,000 | -248,000 | $1,849,000 | $1,557,000 | -$292,000 | 2013-11-13 |
|---|
| Q3 2013 | JEFFERIES GROUP INC NEW
CUSIP 472319AG7 | | DBCV 3.8 | $1,757,000 | $1,509,000 | -248,000 | $1,872,000 | $1,582,000 | -$290,000 | 2013-11-13 |
|---|
| Q3 2013 | HEALTH CARE REIT INC
CUSIP 42217KAR7 | | NOTE 3.0 | $758,000 | $672,000 | -86,000 | $1,003,000 | $831,000 | -$172,000 | 2013-11-13 |
|---|
| Q3 2013 | ALLEGHENY TECHNOLOGIES INC
CUSIP 01741RAD4 | | NOTE 4.2 | $1,143,000 | $977,000 | -166,000 | $1,177,000 | $1,014,000 | -$163,000 | 2013-11-13 |
|---|
| Q3 2013 | INTERNATIONAL GAME TECHNOLOG
CUSIP 459902AQ5 | | NOTE 3.2 | $1,856,000 | $1,655,000 | -201,000 | $1,979,000 | $1,831,000 | -$148,000 | 2013-11-13 |
|---|
| Q3 2013 | PRICELINE COM INC
CUSIP 741503AN6 | | NOTE 1.2 | $1,144,000 | $982,000 | -162,000 | $3,124,000 | $3,258,000 | +$134,000 | 2013-11-13 |
|---|
| Q3 2013 | TYSON FOODS INC
CUSIP 902494AP8 | | NOTE 3.2 | $850,000 | $687,000 | -163,000 | $1,296,000 | $1,176,000 | -$120,000 | 2013-11-13 |
|---|
| Q3 2013 | NOVELLUS SYS INC
CUSIP 670008AD3 | | NOTE 2.6 | $1,238,000 | $1,164,000 | -74,000 | $1,745,000 | $1,843,000 | +$98,000 | 2013-11-13 |
|---|
| Q3 2013 | NEWMONT MINING CORP
CUSIP 651639AJ5 | | NOTE 1.6 | $2,076,000 | $1,942,000 | -134,000 | $2,230,000 | $2,141,000 | -$89,000 | 2013-11-13 |
|---|
| Q3 2013 | FLUOR CORP NEW
CUSIP 343412AA0 | | NOTE 1.5 | $897,000 | $775,000 | -122,000 | $1,930,000 | $1,995,000 | +$65,000 | 2013-11-13 |
|---|
| Q3 2013 | DOMINION RES INC VA NEW
CUSIP 25746UAT6 | | NOTE 2.1 | $807,000 | $695,000 | -112,000 | $1,348,000 | $1,287,000 | -$61,000 | 2013-11-13 |
|---|
| Q3 2013 | XILINX INC
CUSIP 983919AF8 | | NOTE 2.6 | $1,188,000 | $1,023,000 | -165,000 | $1,697,000 | $1,660,000 | -$37,000 | 2013-11-13 |
|---|
| Q2 2013 | JEFFERIES GROUP INC NEW
CUSIP 472319AG7 | | DBCV 3.8 | $2,097,000 | $1,757,000 | -340,000 | $2,156,000 | $1,872,000 | -$284,000 | 2013-12-23 |
|---|
| Q2 2013 | GILEAD SCIENCES INC
CUSIP 375558AP8 | | NOTE 1.6 | $2,941,000 | $2,916,000 | -25,000 | $6,384,000 | $6,599,000 | +$215,000 | 2013-12-23 |
|---|
| Q2 2013 | ALCOA INC
CUSIP 013817AT8 | | NOTE 5.2 | $1,482,000 | $1,457,000 | -25,000 | $2,050,000 | $1,849,000 | -$201,000 | 2013-12-23 |
|---|
| Q2 2013 | FORD MTR CO DEL
CUSIP 345370CN8 | | NOTE 4.2 | $741,000 | $716,000 | -25,000 | $1,187,000 | $1,294,000 | +$107,000 | 2013-12-23 |
|---|
| Q2 2013 | ARCHER DANIELS MIDLAND CO
CUSIP 039483AW2 | | NOTE 0.8 | $2,019,000 | $1,919,000 | -100,000 | $2,039,000 | $1,935,000 | -$104,000 | 2013-12-23 |
|---|
| Q2 2013 | AIRTRAN HLDGS INC
CUSIP 00949PAD0 | | NOTE 5.2 | $1,672,000 | $1,622,000 | -50,000 | $2,402,000 | $2,309,000 | -$93,000 | 2013-12-23 |
|---|
| Q2 2013 | TEVA PHARMACEUTICAL FIN LLC
CUSIP 88163VAE9 | | DBCV 0.2 | $2,433,000 | $2,333,000 | -100,000 | $2,529,000 | $2,444,000 | -$85,000 | 2013-12-23 |
|---|
| Q2 2013 | INTERNATIONAL GAME TECHNOLOG
CUSIP 459902AQ5 | | NOTE 3.2 | $1,906,000 | $1,856,000 | -50,000 | $2,057,000 | $1,979,000 | -$78,000 | 2013-12-23 |
|---|
| Q2 2013 | ALLEGHENY TECHNOLOGIES INC
CUSIP 01741RAD4 | | NOTE 4.2 | $1,163,000 | $1,143,000 | -20,000 | $1,248,000 | $1,177,000 | -$71,000 | 2013-12-23 |
|---|
| Q2 2013 | AFFILIATED MANAGERS GROUP
CUSIP 008252AL2 | | NOTE 3.9 | $2,123,000 | $2,098,000 | -25,000 | $2,638,000 | $2,699,000 | +$61,000 | 2013-12-23 |
|---|
| Q2 2013 | MOLSON COORS BREWING CO
CUSIP 60871RAA8 | | NOTE 2.5 | $1,115,000 | $1,090,000 | -25,000 | $1,151,000 | $1,101,000 | -$50,000 | 2013-12-23 |
|---|
| Q2 2013 | DOMINION RES INC VA NEW
CUSIP 25746UAT6 | | NOTE 2.1 | $815,000 | $807,000 | -8,000 | $1,394,000 | $1,348,000 | -$46,000 | 2013-12-23 |
|---|
| Q2 2013 | DANAHER CORP DEL
CUSIP 235851AF9 | | NOTE | $1,487,000 | $1,437,000 | -50,000 | $2,687,000 | $2,644,000 | -$43,000 | 2013-12-23 |
|---|
| Q2 2013 | NUANCE COMMUNICATIONS INC
CUSIP 67020YAF7 | | NOTE 2.7 | $982,000 | $957,000 | -25,000 | $1,015,000 | $986,000 | -$29,000 | 2013-12-23 |
|---|
| Q2 2013 | LAM RESEARCH CORP
CUSIP 512807AL2 | | NOTE 1.2 | $2,340,000 | $2,249,000 | -91,000 | $2,496,000 | $2,495,000 | -$1,000 | 2013-12-23 |
|---|
| Q1 2013 | MEDTRONIC INC
CUSIP 585055AM8 | | NOTE 1.6 | $1,309,000 | $755,000 | -554,000 | $1,313,000 | $755,000 | -$558,000 | 2013-12-23 |
|---|
| Q1 2013 | JEFFERIES GROUP INC NEW
CUSIP 472319AG7 | | DBCV 3.8 | $2,452,000 | $2,097,000 | -355,000 | $2,429,000 | $2,156,000 | -$273,000 | 2013-12-23 |
|---|
| Q1 2013 | AFFILIATED MANAGERS GROUP
CUSIP 008252AL2 | | NOTE 3.9 | $2,142,000 | $2,123,000 | -19,000 | $2,372,000 | $2,638,000 | +$266,000 | 2013-12-23 |
|---|
| Q1 2013 | DANAHER CORP DEL
CUSIP 235851AF9 | | NOTE | $1,535,000 | $1,487,000 | -48,000 | $2,494,000 | $2,687,000 | +$193,000 | 2013-12-23 |
|---|
| Q1 2013 | TEXTRON INC
CUSIP 883203BN0 | | NOTE 4.5 | $915,000 | $850,000 | -65,000 | $1,732,000 | $1,923,000 | +$191,000 | 2013-12-23 |
|---|
| Q1 2013 | DOMINION RES INC VA NEW
CUSIP 25746UAT6 | | NOTE 2.1 | $820,000 | $815,000 | -5,000 | $1,240,000 | $1,394,000 | +$154,000 | 2013-12-23 |
|---|
| Q1 2013 | ARCHER DANIELS MIDLAND CO
CUSIP 039483AW2 | | NOTE 0.8 | $2,174,000 | $2,019,000 | -155,000 | $2,175,000 | $2,039,000 | -$136,000 | 2013-12-23 |
|---|
| Q1 2013 | NASDAQ OMX GROUP INC
CUSIP 631103AA6 | | NOTE 2.5 | $440,000 | $348,000 | -92,000 | $440,000 | $348,000 | -$92,000 | 2013-12-23 |
|---|
| Q1 2013 | PROLOGIS
CUSIP 74340XAT8 | | NOTE 3.2 | $1,451,000 | $1,441,000 | -10,000 | $1,644,000 | $1,660,000 | +$16,000 | 2013-12-23 |
|---|
| Q1 2013 | TEVA PHARMACEUTICAL FIN LLC
CUSIP 88163VAE9 | | DBCV 0.2 | $2,483,000 | $2,433,000 | -50,000 | $2,536,000 | $2,529,000 | -$7,000 | 2013-12-23 |
|---|